Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 15, 2026
Schwab U.S. Dividend Equity ETF (SCHD) Delivers +6.7% 30-Day Gain on Defensive Income Tilt

Schwab U.S. Dividend Equity ETF (SCHD) Delivers +6.7% 30-Day Gain on Defensive Income Tilt

Key Takeaways

  • SCHD tracks the Dow Jones U.S. Dividend 100 Index, holding approximately 103 dividend-paying U.S. companies through a rules-based quality, yield, and dividend-growth screen.
  • The ETF's latest 30-day price move was roughly +6.7%, a steady advance that remained below the threshold for high-momentum or high-volatility positioning.
  • Over the most recent quarter, SCHD rose about 8.8% on a price basis, supported by health care, financials, information technology, and industrial sector strength within the portfolio.
  • Health care, consumer staples, energy, and technology are the fund's largest sector exposures, giving the portfolio a defensive income tilt with select cyclical drivers.
  • The fund carries a 0.06% expense ratio and manages roughly $100 billion in assets under management (AUM).
  • Key considerations include sector concentration, value and dividend-style rotation, interest-rate expectations, and the earnings resilience of its largest holdings.

Schwab U.S. Dividend Equity ETF (SCHD) Overview

The SCHD is a passively managed exchange-traded fund designed to track the Dow Jones U.S. Dividend 100 Index. The index targets high-dividend-yielding U.S. companies with a record of consistent payouts, then applies fundamental screens based on financial strength relative to industry peers. This rules-based approach produces a portfolio of about 103 large-cap, dividend-paying stocks rather than a simple highest-yield list.

Largest positions recently included Abbott Laboratories, UnitedHealth Group, Merck, Home Depot, Amgen, Procter & Gamble, Coca-Cola, Chevron, PepsiCo, Verizon Communications, and Texas Instruments. Sector exposure is concentrated in health care, consumer staples, energy, and technology, with smaller allocations to financials, industrials, consumer discretionary, and communication services. The fund's low 0.06% expense ratio and quarterly distribution schedule reinforce its role as a cost-efficient equity income vehicle. I also checked this using Tickeron’s AI Screener to see how the ETF compares to peers in the dividend space.

Industry and Thematic Landscape

The broader market environment for dividend and equity income strategies has been defined by a rotation toward cash-flow-generative, fundamentally sound companies. Sectors such as health care and consumer staples offer defensive earnings streams, while energy and financials add sensitivity to commodity prices, credit conditions, and interest rates. Technology exposure within dividend strategies has also become more relevant as mature semiconductor and software-related companies return capital to shareholders.

For SCHD, this sector mix matters because the fund's performance is shaped less by a single macroeconomic theme and more by the interaction of defensive income demand, value rotation, and the earnings trajectory of large-cap dividend payers. In an environment where investors continue to evaluate inflation, monetary policy, and economic growth, quality dividend exposure has remained a central investment theme.

Performance and Positioning Snapshot

SCHD's latest available close of $34.52 compares with a close of roughly $32.34 about 30 calendar days earlier, representing a gain of approximately 6.7% on a price basis. The advance was gradual and trend-driven rather than volatile, with the fund moving steadily higher before consolidating near recent highs. Over the most recent quarter, SCHD advanced from about $31.72 to $34.52, a move of roughly 8.8%.

The fund's sector sleeve performance helps explain the trend. Health care, financials, information technology, and industrials were among the stronger areas within the portfolio during the latest quarter, while energy and consumer staples were more mixed. That combination allowed SCHD to benefit from defensive health care leadership and select cyclical recovery without depending entirely on a single sector. Major holdings in managed care, pharmaceuticals, home improvement retail, and semiconductors contributed to the fund's positioning during the period. I reviewed the latest signals on this using Tickeron’s AI Trend Prediction Engine to confirm the broader sector momentum.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to influence SCHD during 2026. The health care sector will remain important given the fund's largest exposure, with attention on pharmaceutical pipelines, managed-care pricing, and regulatory developments. Consumer staples performance will depend on pricing power, volume trends, and the ability of large branded companies to defend margins. Energy holdings remain tied to commodity prices, capital discipline, and global demand, while financials are sensitive to credit conditions and interest-rate expectations.

Technology exposure may be influenced by semiconductor demand, enterprise spending, and shareholder-return policies. Dividend growth, payout ratios, and any changes to the underlying index's selection methodology also matter for portfolio composition. Finally, capital flows into dividend ETFs, competition from lower-cost or higher-yield products, and the broader macroeconomic environment—including inflation trends, monetary policy, and economic growth—will help determine whether defensive income leadership persists or broadens. Investors should monitor these themes rather than rely on short-term price movements alone.

Tickeron AI Tools for Research

In my own analysis, I find Tickeron’s AI Screener particularly useful for quickly scanning dividend-focused ETFs and comparing sector exposures against broader market trends. The platform pulls together technical indicators, fundamentals, and AI-generated signals in one place, which helps streamline the process of evaluating holdings like those in SCHD without spending hours on manual screens. Explore the AI Screener to see how data-driven discovery can support a more disciplined research process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


SCHD in +0.78% Uptrend, growing for three consecutive days on September 03, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SCHD advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 377 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SCHD turned negative on August 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Notable companies

The most notable companies in this group are ABBVIE (NYSE:ABBV), Cisco Systems (NASDAQ:CSCO), Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Merck & Co (NYSE:MRK), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), Verizon Communications (NYSE:VZ), PepsiCo (NASDAQ:PEP).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF™ ETF is 52.45B. The market cap for tickers in the group ranges from 461.64M to 439.62B. ABBV holds the highest valuation in this group at 439.62B. The lowest valued company is AMSF at 461.64M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF™ ETF was 25%. For the same ETF, the average monthly price growth was 28%, and the average quarterly price growth was 156%. SWKS experienced the highest price growth at 12%, while OXM experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF™ ETF was -6%. For the same stocks of the ETF, the average monthly volume growth was 12% and the average quarterly volume growth was -40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 44
Price Growth Rating: 45
SMR Rating: 41
Profit Risk Rating: 57
Seasonality Score: -15 (-100 ... +100)
View a ticker or compare two or three
SCHD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Profile
Details
Category
Large Value
Address
Schwab Strategic Trust101 Montgomery StreetSan Francisco
Phone
1-800-435-4000
Web
www.csimfunds.com.
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.